(NP (NP-COOD (NP Corticosteroid/NN receptors/NNS) and/CC (NP lymphocyte/NN subsets/NNS)) (PP in/IN (NP (NP mononuclear/JJ leukocytes/NNS) (PP in/IN (NP aging/NN)))) ./.)
(S (NP-SBJ-42 (NP-COOD (NP Plasma/NN cortisol/NN) and/CC (NP (NP aldosterone/NN (NP-COOD (NP levels/NNS) and/CC (NP number/NN))) (PP of/IN (NP related/JJ receptors/NNS)))) (PP in/IN (NP mononuclear/JJ leukocytes/NNS))) (VP were/VBD (VP measured/VBN (NP *-42/-NONE-) (PP-COOD (PP in/IN (NP (NP 49/CD healthy/JJ aged/JJ subjects/NNS) (PRN -LRB-/-LRB- (FRAG (NP (QP 62-97/CD) yr/NN)) -RRB-/-RRB-))) and/CC (PP in/IN (NP (NP 21/CD adult/JJ controls/NNS) (PRN -LRB-/-LRB- (FRAG (NP (QP 21-50/CD) yr/NN)) -RRB-/-RRB-)))))) ./.)
(S (PP In/IN (NP all/DT subjects/NNS)) ,/, (PP in/IN (NP addition/NN)) ,/, (NP-SBJ-43 lymphocyte/NN subsets/NNS) (VP were/VBD (VP determined/VBN (NP *-43/-NONE-) (PP as/IN (NP (NP an/DT index/NN) (PP of/IN (NP corticosteroid/NN action/NN)))))) ./.)
(S (NP-SBJ (NP The/DT mean/NN number/NN) (PP of/IN (NP (NP-COOD (NP type/NN I/CD) and/CC (NP type/NN II/CD)) receptors/NNS))) (VP (VP was/VBD (ADJP-PRD (ADJP significantly/RB lower/JJR) (PP *ICH*-44/-NONE-)) (PP in/IN (NP aged/JJ subjects/NNS)) (PP-44 than/IN (FRAG (PP in/IN (NP controls/NNS))))) (PRN -LRB-/-LRB- (FRAG (ADVP respectively/RB) ,/, (NP (NP-COOD (NP (NP (QP 198/CD +\/-/CC 96/CD and/CC 272/CD +\/-/CC 97/CD) receptors\/cell/NNS) (PP for/IN (NP type/NN I/CD (NP *RNR*-45/-NONE-)))) ,/, and/CC (NP (NP (QP 1,794/CD +\/-/CC 803/CD and/CC 3,339/CD +\/-/CC 918/CD)) (PP for/IN (NP type/NN II/CD (NP *RNR*-45/-NONE-))))) (NP-45 receptors/NNS))) -RRB-/-RRB-)) ./.)
(S (NP-SBJ-COOD (NP Plasma/NN (NP-COOD (NP aldosterone/NN) and/CC (NP cortisol/NN))) and/CC (NP lymphocyte/NN subsets/NNS)) (VP were/VBD not/RB (ADJP-PRD different/JJ) (PP in/IN (NP the/DT two/CD groups/NNS))) ./.)
(S-COOD (S (NP-SBJ-46 (NP All/DT) (PP of/IN (NP the/DT parameters/NNS))) (VP were/VBD (ADVP also/RB) (VP tested/VBN (NP *-46/-NONE-) (PP for/IN (NP correlation/NN))))) ,/, and/CC (S (NP-SBJ-47 a/DT significant/JJ inverse/JJ correlation/NN) (VP was/VBD (VP found/VBN (NP *-47/-NONE-) (PP between/IN (NP-COOD (NP age/NN) and/CC (NP (NP-COOD (NP type/NN I/CD) and/CC (NP type/NN II/CD)) receptors/NNS))) (SBAR-TMP (WHADVP-48 when/WRB) (S (NP-SBJ-49 all/DT subjects/NNS) (VP were/VBD (VP plotted/VBN (NP *-49/-NONE-) and/CC (PP between/IN (NP aged/JJ and/CC CD4/NN and/CC age/NN and/CC CD4\/CD8/NN)) (PP in/IN (NP the/DT aged/JJ group/NN)) (ADVP *T*-48/-NONE-)))))))) ./.)
(S (NP-SBJ These/DT data/NNS) (VP show/VBP (SBAR-COOD (SBAR that/IN (S (NP-SBJ aged/JJ subjects/NNS) (VP have/VBP (NP (NP reductions/NNS) (PP of/IN (NP corticosteroid/NN receptors/NNS)) (SBAR (WHNP-50 that/WDT) (S (NP-SBJ-51 *T*-50/-NONE-) (VP are/VBP not/RB (VP associated/VBN (NP *-51/-NONE-) (PP with/IN (NP (NP increase/NN) (PP of/IN (NP related/JJ steroids/NNS)))))))))))) and/CC (SBAR that/IN (S (NP-SBJ this/DT situation/NN) (ADVP probably/RB) (VP represents/VBZ (NP (NP a/DT concomitant/NN) (PP of/IN (NP the/DT normal/JJ aging/NN process/NN)))))))) ./.)
